
Telwis AMH 40mg/5mg/12.5mg Tablet
Marketer
Syswin Pharmaceuticals Pvt Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telwis AMH 40mg/5mg/12.5mg Tablet
Amlodipine/Hydrochlorothiazide/Valsartan 40mg/5mg/12.5mg tablets are a triple-combination therapy for managing hypertension when monotherapy proves insufficient. This medication lowers elevated blood pressure, mitigating the risk of future cardiovascular events such as stroke and myocardial infarction. This medication may be taken with or without food; dosage is individualized based on patient response and health status. Consistent daily dosing is recommended. Continue this treatment as directed by your physician. Due to its diuretic component, which increases urination, avoid administration within four hours of bedtime. Regular use, even during asymptomatic periods, maximizes therapeutic benefit. Discontinuation can elevate the risk of stroke or heart attack. Commonly reported side effects include fatigue, headache, dizziness, altered taste perception, flu-like symptoms, diarrhea, and sinus inflammation. Report any persistent, worsening, or bothersome side effects to your doctor. Increase fluid intake to alleviate potential symptoms such as thirst, dry mouth, and muscle weakness. Prior to commencing treatment, inform your physician of any pre-existing liver or kidney conditions. Pregnant or lactating individuals should seek medical counsel before use. Comprehensive disclosure of all current medications, especially those for hypertension or cardiac issues, is crucial. Regular monitoring of blood pressure, renal function, electrolyte levels, and glycemia is necessary to ensure optimal treatment efficacy.
Uses of Telwis AMH 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Telwis AMH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telwis AMH 40mg/5mg/12.5mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Telwis AMH 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telwis AMH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telwis AMH 40mg/5mg/12.5mg Tablets can be consumed with or without food, though consistent daily timing is recommended.
How Telwis AMH 40mg/5mg/12.5mg Tablet works:
A single tablet of Telwis AMH (40mg telmisartan, 5mg amlodipine, 12.5mg hydrochlorothiazide) combines an angiotensin receptor blocker (ARB, telmisartan), a calcium channel blocker (CCB, amlodipine), and a diuretic (hydrochlorothiazide). Amlodipine and telmisartan lower blood pressure by promoting vasodilation, widening blood vessels. Hydrochlorothiazide reduces blood pressure by increasing urine output, eliminating excess fluid and electrolytes, and contributing to long-term vascular relaxation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telwis AMH 40mg/5mg/12.5mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Telwis AMH 40mg/5mg/12.5mg tablets during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Exceptions might be made in critical circumstances where a physician deems the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Telwis AMH 40mg/5mg/12.5mg tablets while breastfeeding is contraindicated due to the potential for infant harm from drug-related toxicity.
DrivingUNSAFE
Driving ability may be impaired by side effects of Telwis AMH 40mg/5mg/12.5mg Tablets, including dizziness, headache, nausea, or fatigue, which can impact concentration.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telwis AMH 40mg/5mg/12.5mg tablets, as dose modification may be necessary. Consult a physician before use; the medication is generally unsuitable for individuals with severely compromised kidney function.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Telwis AMH 40mg/5mg/12.5mg tablets. Dosage modification of Telwis AMH 40mg/5mg/12.5mg tablets may be necessary. Physician consultation is recommended.
What if you forget to take Telwis AMH 40mg/5mg/12.5mg Tablet :
Should you forget to take your Telwis AMH 40mg/5mg/12.5mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telwis AMH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
